No Prescription |
 |
 | ||
|
Lescol XL Lescol |
|
| ||
No Prescription » Prescription Drugs 10 » Lescol XL Lescol Product Origin: EU (Turkey)This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English.Medical Information:Lowering high cholesterol and triglycerides in certain patients. It also increases high-density lipoprotein (HDL "good") cholesterol levels. It is used along with an appropriate diet. It is used in certain patients to slow blood vessel blockage and to reduce the need for medical procedures to open blocked heart blood vessels. It may also be used for other conditions as determined by your doctor.Lescol XL Extended-Release Tablets is an HMG-CoA reductase inhibitor also known as a "statin." It works by reducing the production of certain fatty substances in the body including cholesterol.Fluvastatin is a cholesterol-lowering medication that blocks the production of cholesterol (a type of fat) in the body.Fluvastatin reduces low-density lipoprotein (LDL) cholesterol and total cholesterol in the blood. Lowering your cholesterol can help prevent heart disease and hardening of the arteries conditions that can lead to heart attack stroke and vascular disease.Increases rate at which body removes cholesterol from blood and reduces production of cholesterol in body by inhibiting enzyme that catalyzes early rate-limiting step in cholesterol synthesis; increases HDL; reduces LDL VLDL and triglycerides. Buy Lescol XL Lescol and other Prescription Drugs 10 products online at Medstore. 3682
About Lescol XL Lescol: Product Type: Prescription Drugs 10 Lescol XL ( Lescol Generic Fluvastatin ) Lescol XL (Lescol Generic Fluvastatin) Lescol Generic Fluvastatin 80mg 28 Tablets Lescol Generic Fluvastatin Lescol XL
View more Prescription Drugs 10 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
